GSE201412
Anti-tumor efficacy of a potent and selective non-covalent KRASG12D inhibitor
We report the expression result for the invivo and invitro cell lines treated with MRTX1133 Overall design: We report the expression result for the invivo and invitro cell lines treated with MRTX1133